FDA Inspection 864547 — Sentry Biopharma Services, Inc.

Sentry Biopharma Services, Inc. — FEI 3007066137

The FDA completed an inspection of Sentry Biopharma Services, Inc. on February 3, 2014 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 3, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)